Merck & Co., Inc. (MRK) Forecast: Analyst Ratings & Targets

Latest MRK Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Mar 30, 2026	Trung Huynh	RBC Capital	Reiterates	Buy	$142.00 → $142.00 +0.00 (0.0%)
Mar 20, 2026	Geoff Meacham	Citi	Maintains	Hold	$120.00 → $125.00 +5.00 (4.2%)
Mar 12, 2026	Mohit Bansal	Wells Fargo	Maintains	Buy	$135.00 → $150.00 +15.00 (11.1%)
Feb 25, 2026	Trung Huynh	RBC Capital	Initiates	Buy	$142.00
Feb 20, 2026	Emily Field	Barclays	Initiates	Buy	$140.00
Feb 9, 2026	Ilya Zubkov	Freedom Broker	Maintains	Hold	$90.00 → $110.00 +20.00 (22.2%)
Feb 6, 2026	Vamil Divan	Guggenheim	Maintains	Strong Buy	$122.00 → $140.00 +18.00 (14.8%)
Feb 4, 2026	Carter Gould	Cantor Fitzgerald	Maintains	Hold	$116.00 → $120.00 +4.00 (3.5%)
Feb 4, 2026	Geoff Meacham	Citi	Maintains	Hold	$115.00 → $120.00 +5.00 (4.3%)
Feb 4, 2026	Mohit Bansal	Wells Fargo	Maintains	Buy	$125.00 → $135.00 +10.00 (8.0%)
Jan 27, 2026	Geoff Meacham	Citi	Maintains	Hold	$110.00 → $115.00 +5.00 (4.5%)
Jan 20, 2026	Steve Scala	TD Cowen	Maintains	Hold	$100.00 → $120.00 +20.00 (20.0%)
Jan 8, 2026	Alexandria Hammond	Wolfe Research	Upgrades	Buy	$135.00
Jan 7, 2026	Trung Huynh	UBS	Maintains	Strong Buy	$105.00 → $130.00 +25.00 (23.8%)
Jan 7, 2026	Geoff Meacham	Citi	Maintains	Hold	$95.00 → $110.00 +15.00 (15.8%)

Trung Huynh

RBC Capital

BuyReiterates

$142.00 → $142.00

Mar 30

Geoff Meacham

Citi

HoldMaintains

$120.00 → $125.00

Mar 20

Mohit Bansal

Wells Fargo

BuyMaintains

$135.00 → $150.00

Mar 12

Trung Huynh

RBC Capital

BuyInitiates

$142.00

Feb 25

Emily Field

Barclays

BuyInitiates

$140.00

Feb 20

Ilya Zubkov

Freedom Broker

HoldMaintains

$90.00 → $110.00

Feb 9

Vamil Divan

Guggenheim

Strong BuyMaintains

$122.00 → $140.00

Feb 6

Carter Gould

Cantor Fitzgerald

HoldMaintains

$116.00 → $120.00

Feb 4

Geoff Meacham

Citi

HoldMaintains

$115.00 → $120.00

Feb 4

Mohit Bansal

Wells Fargo

BuyMaintains

$125.00 → $135.00

Feb 4

Geoff Meacham

Citi

HoldMaintains

$110.00 → $115.00

Jan 27

Steve Scala

TD Cowen

HoldMaintains

$100.00 → $120.00

Jan 20

Alexandria Hammond

Wolfe Research

BuyUpgrades

$135.00

Jan 8

Trung Huynh

UBS

Strong BuyMaintains

$105.00 → $130.00

Jan 7

Geoff Meacham

Citi

HoldMaintains

$95.00 → $110.00

Jan 7

Frequently Asked Questions

What is the analyst consensus rating for MRK?

The analyst consensus rating for MRK is "Buy" based on 10 analyst recommendations.

What is the average price target for MRK?

The average 12-month price target for MRK is $131.20, representing an upside of 8.5% from the current price of $120.87.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Merck & Co., Inc. (MRK) Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest MRK Analyst Ratings & Recommendations

Frequently Asked Questions